Guy Griebel Selected Research

Hypersensitivity (Allergy)

11/2005

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Griebel Research Topics

Disease

12	Schizophrenia (Dementia Praecox) 10/2016 - 11/2005
6	Anxiety Disorders (Anxiety Disorder) 11/2012 - 04/2002
3	Neurobehavioral Manifestations 10/2016 - 01/2007
2	Memory Disorders (Memory Loss) 01/2018 - 01/2007
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018 - 02/2015
2	Body Weight (Weight, Body) 01/2014 - 04/2002
2	Mental Disorders (Mental Disorder) 05/2012 - 01/2012
2	Depressive Disorder (Melancholia) 01/2012 - 02/2008
2	Cognitive Dysfunction 05/2011 - 05/2011
2	Mood Disorders (Mood Disorder) 05/2011 - 04/2002
2	Ataxia (Dyssynergia) 06/2005 - 01/2003
2	Tobacco Use Disorder (Nicotine Dependence) 06/2005 - 01/2005
1	Alzheimer Disease (Alzheimer's Disease) 12/2019
1	Seizures (Absence Seizure) 01/2015
1	Visceral Pain 01/2015
1	Obesity 01/2014
1	Sleep Wake Disorders 11/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2013
1	Treatment-Resistant Depressive Disorder 01/2013
1	Major Depressive Disorder (Major Depressive Disorders) 11/2012
1	Acute Traumatic Stress Disorders (Acute Stress Disorder) 05/2011
1	Catalepsy 05/2011
1	Weight Gain 05/2011
1	Schizotypal Personality Disorder 01/2009
1	Hypersensitivity (Allergy) 11/2005
1	Dehydration (Water Stress) 01/2005
1	Bites and Stings (Sting) 03/2004
1	Spasm (Spasms) 01/2003
1	Muscle Weakness 01/2003
1	Retinoblastoma (Glioblastoma, Retinal) 04/2002
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2002

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
4	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 11/2012 - 09/2003
4	Vasopressins (Vasopressin)IBA 11/2012 - 04/2002
3	SSR125543IBA 02/2015 - 05/2011
3	Phencyclidine (Angel Dust)IBA 10/2013 - 11/2005
3	Antipsychotic Agents (Antipsychotics)IBA 05/2011 - 01/2009
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2005 - 01/2003
2	CannabinoidsIBA 01/2018 - 05/2011
2	N-Methylaspartate (NMDA)IBA 10/2016 - 02/2015
2	Serotonin (5 Hydroxytryptamine)IBA 02/2015 - 07/2013
2	TachykininsIBA 01/2015 - 05/2012
2	NeurotensinIBA 01/2015 - 05/2012
2	NeuropeptidesIBA 01/2015 - 11/2003
2	LigandsIBA 01/2015 - 05/2012
2	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2015 - 05/2012
2	Corticotropin-Releasing HormoneIBA 05/2012 - 05/2011
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2011 - 06/2005
2	Dopamine (Intropin)FDA LinkGeneric 01/2011 - 01/2010
2	SSR180711IBA 06/2009 - 01/2007
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 06/2009 - 01/2007
2	2- chloro- N- ((S)- phenyl((2S)- piperidin- 2- yl)methyl)- 3- trifluoromethyl benzamideIBA 01/2009 - 11/2005
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2009 - 11/2008
2	6- fluoro- 9- methyl- 2- phenyl- 4- (pyrrolidin- 1- yl- carbonyl)- 2,9- dihydro- 1H- pyrido(3,4- b)indol- 1- oneIBA 06/2005 - 01/2003
2	Nicotine FDA Link 06/2005 - 01/2005
2	Hormones (Hormone)IBA 01/2005 - 04/2002
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2005 - 04/2002
2	4- (2- chloro- 4- methoxy- 5- methylphenyl)- N(2- cyclopropyl- 1- (3- fluoro- 4- methylphenyl)ethyl)- 5- methyl- N- (2- propynyl)- 1,3- thiazol- 2- amineIBA 04/2002 - 04/2002
1	EnzymesIBA 12/2019
1	Glycogen Synthase Kinase 3IBA 12/2019
1	tau Proteins (tau Protein)IBA 12/2019
1	SAR218645IBA 10/2016
1	Glutamic Acid (Glutamate)FDA Link 10/2016
1	metabotropic glutamate receptor 2IBA 10/2016
1	Paroxetine (Paxil)FDA LinkGeneric 02/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2015
1	Cycloserine (Seromycin)FDA Link 02/2015
1	SAR127303IBA 01/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015
1	Tachykinin Receptors (Tachykinin Receptor)IBA 01/2015
1	CryptochromesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2013
1	tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amideIBA 11/2013
1	Hypnotics and Sedatives (Sedatives)IBA 07/2013
1	Neurokinin-3 ReceptorsIBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	ProlactinIBA 05/2011
1	SR 48968 (saredutant)IBA 05/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2011
1	Diazepam (Valium)FDA LinkGeneric 05/2011
1	AVE1625IBA 05/2011
1	BenzodiazepinesIBA 05/2011
1	(3- exo)- 8- benzoyl- N- (((2S)7- chloro- 2,3- dihydro- 1,4- benzodioxin- 1- yl)methyl)- 8- azabicyclo(3.2.1)octane- 3- methanamine monohydrochlorideIBA 01/2011
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2009
1	Amphetamine (Amfetamine)FDA LinkGeneric 06/2009
1	Nitroarginine (NG Nitro L Arginine)IBA 06/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2008
1	ST 679IBA 11/2005
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 11/2005
1	EndocannabinoidsIBA 06/2005
1	SmokeIBA 06/2005
1	RimonabantIBA 06/2005
1	CRF receptor type 1IBA 03/2004
1	Antidepressive Agents (Antidepressants)IBA 09/2003
1	GABA-A Receptor AgonistsIBA 01/2003

Therapy/Procedure

2	Therapeutics 01/2014 - 05/2012
1	Deep Brain Stimulation 01/2013
1	Drug Therapy (Chemotherapy) 11/2003